Publications:131
David F Putrino, PhD
About Me
Dr. David Putrino is an Official Medical Provider for Red Bull’s Sponsored Athletes in North America.
David has a PhD in Neuroscience. He worked as a clinician in Australia, before moving to the United States to study computational neuroscience at Harvard Medical School, MIT and NYU. He has served as a faculty member at Weill-Cornell Medicine and Burke Medical Research Institute.
He is currently the Director of Rehabilitation Innovation for the Mount Sinai Health System, and a Professor in the Department of Rehabilitation and Human Performance at the Icahn School of Medicine at Mount Sinai. He works to develop innovative technology solutions for individuals in need of better healthcare accessibility.
He consults with the Red Bull High Performance division to use evidence-based technologies to improve athletic performance. He is also the “Chief Mad Scientist” of Not Impossible Labs, a group that crowd-sources accessible technological solutions for high-impact humanitarian problems. David’s research has been featured on the ABC, Sport’s Illustrated, the Wall Street Journal, the BBC, Time, Wired and the LA Times to name just a few.
Language
English
Position
PROFESSOR | Rehabilitation and Human Performance
Research Topics
Cell Biology, Cognitive Neuroscience, Molecular Biology, Neurophysiology, Neuroscience
Education
PhD, The University of Western Australia
Publications
Selected Publications
- Bringing rehabilitation medicine to light: Preliminary outcomes of a novel multi-institutional workshop for high school students. Steve Park, Adedeji Adeniyi, Emma Van Praagh, Shrey Patel, Paul Lewis, Marie Mazzeo-Weaver, Oranicha Jumreornvong, Raysha Farah, Jiawei Chen, Brianna Ingrid Lubin, Mar Ariana Perez Gavancho, Daelyn Peña, Vanessa Kapllani, Brianna A. Edgar, Nora Prince, Gabriela Fabela, Yuliana N. Blanco, Jaciara N. De Souza, Loren Fishman, Sunil K. Agrawal, David Putrino. PM&R
- Recommended long COVID outcome measures and their implications for clinical trial design, with a focus on post-exertional malaise. Letícia Soares, Hannah Davis, Ezra Spier, Tiffany Walker, Todd Davenport, David Putrino, Michael Peluso, Julia Moore Vogel. eBioMedicine
- Initial estimates of the minimal clinically important difference for the Neuropathic Pain Symptom Inventory: a systematic meta-analysis. Alexandra Canori, Rebecca Howard, Jeffrey Bower, David Putrino, Laura Tabacof. Frontiers in Pain Research
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Putrino during 2025 and/or 2026. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Board Service
- Social Creatures
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
- Precision Recovery
- BeCare, LLC
Founder/Co-Founder/Partner
- Precision Recovery
Outside Employment
- Thorne HealthTech
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.